Skip to content
10-Q

Quarterly Report

Acurx Pharmaceuticals, Inc. ACXP

0001558370-25-007371

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 12, 2025 23.48M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $2.49M
Current Liabilities Q1 2025 · Dec 31, 2024 $3.24M
Total Liabilities Q1 2025 · Mar 31, 2025 $2.49M
Total Liabilities Q1 2025 · Dec 31, 2024 $3.24M
Current Assets Q1 2025 · Mar 31, 2025 $4.81M
Current Assets Q1 2025 · Dec 31, 2024 $3.86M
Shares Diluted Q1 2025 · Mar 31, 2024 15.47M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$3.06M
Stockholders Equity Q1 2025 · Mar 31, 2024 $6M
Stockholders Equity Q1 2025 · Dec 31, 2023 $4.67M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.28
Eps Basic Q1 2025 · Mar 31, 2024 −$0.28
Rd Expense Q1 2025 · Mar 31, 2024 $1.56M
Net Income Q1 2025 · Mar 31, 2024 −$4.38M